Bioinformatics Project Final
1. Protein information
Protein information; location in the body as function of time and place; active site; function; functioning; nearest homologous families; is the structure of the protein known, or if not, is there a homolog in the PDB from which the structure could be modelled by homology (full length or domain only); if the structure is known, where are the mutations located on the structure and which effect do you expect from the mutation (protein won't fold, reduced binding to receptor, etc); domain structure of the protein; other functional sites; etc.
Disease: Type 1 diabetes
Protein: Insulin
Location in the body: Insulin is produced by beta cells in the pancreas
Active site of insulin: Insulin attaches and signals to the cells to absorb sugar which is used as energy in the bloodstream.
Function of Insulin: Insulin plays several roles in the body.
The key role of insulin is controlling blood glucose level in the body. When blood glucose level rises, the amount of insulin secreted into the blood increases. Similarly, when blood glucose level falls, the amount of insulin secreted into the blood decreases. Insulin controls blood glucose levels by signalling cells to take in glucose and ensures there is sufficient amount of glucose produced by the liver. When there is low levels of insulin in the body, it signals the liver to produce and release more insulin. When there is high levels of insulin in the body, it signals the liver to take in and store glucose as glycogen to prevent glucose production.
Another role of insulin is to promote synthesis of fatty acids in the liver. As the liver is full of glycogen from high levels of insulin in the body, additional glucose taken in by the liver is released as lipoprotein. Lipoprotein is then ripped apart to produce fatty acids which are used as tissues and adipocytes to form triglycerides. Insulin also helps to accumulate triglyceride in fat cells. Lipoproteins are molecules made up of proteins and lipids. They allow fats to be carried to the bloodstream.
Nearest homologous family of Insulin: Relaxin Peptide Family
Relaxin Family Peptides belong to the human insulin superfamily of polypeptide hormones which consists of seven Relaxin family peptides. The seven Relaxin family peptides have two subfamilies of Relaxin peptides and insulin-like peptides. There are three relaxin peptides - Relaxin-1, Relaxin-2, Relaxin-3 and four insulin-like peptides - insulin-like peptide-3 (INSL3), insulin-like peptide-4 (INSL4), insulin-like peptide-5 (INSL5), insulin-like peptide-6 (INSL6).
Relaxin Family Peptides are structurally similar to insulin and play a wide variety of psychological roles in humans. They are bound to G-protein coupled receptors (GPCRs) and Relaxin family peptide receptors 1-4 (RXFP1-4). GPCRs act as messengers to inform cells about the presence/absence of nutrients in an environment and convey information sent by other cells. RXFP1-4 are for glycoprotein hormones such as follicle-stimulating hormone (TSH) and thyroid-stimulating hormone (TSH).
Relaxin, Relaxin peptides and Insulin-like peptides
Relaxin consists of 53 amino acid peptides containing six cysteine residues to form three disulphide bonds - one intra chain within A-peptide chain and two inter-chain disulphide bonds between A- and B-peptide chains. It plays roles in male and female reproduction, neuropeptide in the central nervous system (CNS). A Relaxin gene produces Relaxin peptides that circulate in the blood during pregnancy. This shows that Relaxin plays a role in early stages and cardiovascular changes of pregnancy. Insulin-like peptides play key roles in metabolism, growth, reproduction and ageing.
Relaxin-1, Relaxin-2 and Relaxin-3
Structure: Relaxin-1, 2 and 3 have three disulphide bonds and a two-chain structure that consist of A- and B- peptide chains. Although relaxin-3 has similar structures as relaxin-1 and 2, it cannot be prepared by combining individual chains together. It uses regioselective disulphide bond strategy. Relaxin-3 is acquired by solid phase synthesis of the separate, selectively S-protected A- and B- peptide chains and their purification and subsequent stepwise formation of each of the three disulphide bonds.
Function: Relaxin 1 and 2 enhances sperm motility, regulates blood pressure, controls heart rate and releases oxytocin and vasopressin. They also play key roles in inflammatory and matrix remodelling processes. Furthermore, relaxin-2 is the only relaxin to circulate in the blood. Relaxin 3 activates and binds to native Relaxin receptors in vitro and stimulates water drinking through central Relaxin receptors in vitro.
INSL3, INSL4, INSL5 and INSL6
Structure: INSL3, 4, 5 and 6 consist of three disulphide bonds and a complex two-chain hormone.
Function: INSL3 plays a key role in testicular descent during pregnancy and is a large gender-specific hormone in bone metabolism. It is a parameter in comparing testosterone and is used to assess Leydig cell functional capacity in testes and to analyse factors affecting hypothalamic pituitary gonadal axis. INSL4 plays key roles in trophoblast development of placenta and uterus and in bone development. INSL5 plays a key role in regulation of insulin secretion and beta cell homeostasis. It is also an orexigenic gastrointestinal hormone released from colonic L-cells that promotes appetite when energy levels are low. INSL6 is produced by the body and it relays growth signals to the body. It plays a key role in male fertility and promotes growth during nutritional deprivation.
What is the active site of a protein?
It consists of both the secondary and tertiary structures, proteins adopt specific shapes. The spot at which two molecules with specific shapes fit together to interact is called the active site. This active site is the basis of the lock and key model. The active site is called active because interaction of the molecules in this way usually results in some chemical change or reaction. Figure 1 is a representation of a small molecule (green helix) interacting with a large molecule (gray globular shape with yellow, orange and red colors) in the active site. The colored regions indicate where the large molecule touches the small one. (Refer to figure 1)
What is the structure of the protein(insulin)?
Normal insulin that is biologically active is monomeric or exists as a single molecule. It has two long amino acid chains or polypeptide chains. The chains are chain A with 21 amino acids and chain B with 30 amino acid. (Refer to figure below)
Where are the mutations located on the structure?
Mutations located at the insulin gene cause disorders of glucose homeostasis through effects of the mutant insulin on beta cell function, insulin receptor affinity, or processing of proinsulin to insulin. The effects of the mutations on glucose homeostasis are variable with associated phenotypes ranging from permanent neonatal diabetes with complete insulin deficiency to near-normal glucose homeostasis. Maturity-onset diabetes of the young (MODY) and type 1b diabetes mellitus are other clinical manifestations of heterozygous insulin gene mutations.
What effects do you expect from the mutation?
As gene mutations can prevent one or more of these proteins from working properly. By changing a gene’s instructions for making a protein, a mutation will result in the protein to malfunction or to be missing entirely. When a mutation alters a protein that plays a critical role in the body, it will disrupt the normal development or cause a medical condition. A condition caused by mutations in one or more genes is called a genetic disorder.
2. Disease symptoms
Disease; symptoms; other diseases caused by the same protein(insulin); are receptors involved and if so what do you know about them; can a diet or other conditions help the patient; what is the life-expectancy; how did the disease get its name; etc.
What is Type 1 diabetes?
Type 1 diabetes is a chronic (lifelong) disease in which there is high blood glucose or hyperglycemia in your blood. It occurs during childhood (most of the cases) but can also occur in adults. It is caused by genetic, autoimmunity or viral infection. It is a more severe form of diabetes in which the pancreas produces little or no insulin due to non-functional beta cells. In type 1 diabetes, the body’s immune system attacks the pancreas as it mistakenly sees insulin-producing beta cells in the pancreas as foreign substances and destroys them.This autoimmune destruction progresses without notice over time until the mass of these cells decreases to the extent that the amount of insulin produced is insufficient for controlling blood glucose levels in the body.
How can insulin damage the body?
Insulin is produced by beta cells in the pancreas to control blood glucose levels in the body. It can damage the body when the body stops making insulin due to type 1 diabetes which causes insulin to not function properly. Insulin serves as a “key” to open your cells and allows glucose to enter to use it as energy for the body. Without insulin, there is no “key.” Hence, glucose does not enter your cells but instead builds up in your blood. The cells starve and die from the lack of glucose.
The building of glucose in your blood causes high blood glucose, which can lead to:
The symptoms of type 1 diabetes are often subtle, however they can also be severe. They consists of:
What are the complications?
Type 1 diabetes can affect major organs in your body, including heart, blood vessels, nerves, eyes and kidneys. Keeping your blood sugar level close to normal most of the time can dramatically reduce the risk of many complications.
Long-term complications of type 1 diabetes develop gradually, over decades. Good blood sugar management can help lower the risk of complications. Eventually, diabetes complications may be disabling or even life-threatening.
Furthermore, there are also short term Diabetes Complications which is known as Hypoglycemia. Hypoglycemia is low blood glucose (blood sugar). It develops when there’s too much insulin—meaning that you’ve taken (or given your child) too much insulin or that you haven’t properly planned insulin around meals or exercise. Other possible causes of hypoglycemia include certain medications (aspirin, for example, lowers the blood glucose level if you take a dose of more than 81mg) and alcohol (alcohol keeps the liver from releasing glucose).
There are three levels of hypoglycemia, depending on how low the blood glucose level has dropped: mild, moderate, and severe. If you treat hypoglycemia when it’s in the mild or moderate stages, then you can prevent far more serious problems; severe hypoglycemia can cause a coma and even death (although it is very rare).
Can the protein (insulin) cause any other disease besides Type 1 diabetes?
It can also cause type 2 diabetes or known as non-insulin-dependent diabetes mellitus. This begins as a syndrome of insulin resistance. That is, target tissues fail to respond appropriately to insulin. Typically, the onset of this disease is in adulthood. Despite monumental research efforts, the precise nature of the defects leading to type II diabetes have been difficult to ascertain, and the pathogenesis of this condition is plainly multifactorial. On the other hand, Obesity is clearly a major risk factor, but in some cases of extreme obesity in humans and animals, insulin sensitivity is normal. Because there is not, at least initially, an inability to secrete adequate amounts of insulin, insulin injections are not useful for therapy. Rather the disease is controlled through dietary therapy and hypoglycemic agents.
Furthermore, it can also result in Hyperinsulinemia or excessive insulin secretion which are most commonly a consequence of insulin resistance, associated with type 2 diabetes or metabolic syndrome. More rarely, hyperinsulinemia results from an insulin-secreting tumor (insulinoma) in the pancreas. Hyperinsulinemia due to accidental or deliberate injection of excessive insulin is dangerous and can be acutely life-threatening because blood levels of glucose drop rapidly and the brain becomes starved for energy (insulin shock).
Receptors involved in Type 1 diabetes
The receptors involved in type 1 diabetes are NKp46 receptor and Toll-like receptor 3 (TLR3).
NKp46 receptor plays a critical role in the development of the disease. BL-9020 is an antibody treatment to prevent destruction of insulin producing beta cells in the pancreas. It targets the NKp46 receptor which is involved in the innate immune response against the pancreas to destroy beta cells. Research has shown that this could significantly delay the maturation of the disease and potentially prevent the disease. This is not scientifically proven yet and is still under research.
Toll-like receptor 3 also plays a crucial role in the development of the disease. It is
involved in the innate immune response triggered by viral infection for the disease.
Can a diet or other conditions help the patient?
Firstly, create a diabetes management plan to help him or her manage the condition and stay healthy and active at the same time. Furthermore, treatment plans for type 1 diabetes are based on each patient's needs and the suggestions of the diabetes healthcare team. Treatment approaches differ in, among other things, the types of insulin given and the schedules for giving insulin given each day. The advantages and disadvantages of a plan should be considered for each patient. However, the basics of the treatment goals for patients with diabetes are to control the condition in a way that minimizes symptoms, prevents short- and long-term health problems, and helps them to have normal physical, mental, emotional, and social growth and development. To achieve this, all people should aim for the goal of keeping blood sugar levels as close to normal as possible.
Does Type 1 Diabetes affect life expectancy?
According to a study, type 1 diabetes reduces life expectancy for male around 11 years whereas for females it is around 13 years.Diabetes' impact on heart health appeared to be the largest single cause of lost years, according to the study. But, the researchers also found that type 1 diabetics younger than 50 are dying in large numbers from conditions caused by issues in management of the disease -- diabetic coma caused by critically low blood sugar, and ketoacidosis caused by a lack of insulin in the body. Furthermore, these conditions reflect through the day-to-day challenge that people with type 1 diabetes continue to face. For example,how to get the right amount of insulin delivered at the right time to deal with your blood sugar levels.
How did Type 1 diabetes get its name?
Type 1 diabetes is a form of diabetes mellitus. The term diabetes is the shortened version of the full name diabetes mellitus. Diabetes mellitus is derived from the Greek word diabetes meaning siphon - to pass through and the Latin word mellitus meaning honeyed or sweet. This is because in diabetes excess sugar is found in blood as well as the urine. It was known in the 17th century as the “pissing evil”.
The term diabetes was probably coined by Apollonius of Memphis around 250 BC. Diabetes is first recorded in English, in the form diabete, in a medical text written around 1425. It was in 1675 that Thomas Willis added the word “'mellitus'” to the word diabetes. This was because of the sweet taste of the urine. This sweet taste had been noticed in urine by the ancient Greeks, Chinese, Egyptians, Indians, and Persians as is evident from their literature.
3. Population
Population; where does disease occur; age of patients; quality of life of patients; is disease a danger to our civilisation; etc.
What is the age group that usually suffers from this disease?
According to a study, Every year in the United States, 13,000 children are diagnosed with type 1 diabetes, and more than 1 million American kids and adults deal with the disease every day. Therefore, it is a disease more commonly found in children. Furthermore, Type 1 diabetes can affect anyone, however it is more common towards people under 30 years and tends to begin in childhood. Other names for type 1 diabetes have included juvenile diabetes and insulin-dependent diabetes mellitus (IDDM).
How does this disease affect the quality life of patients?
It can affect a person emotionally, for example:
As blood-sugar levels can cause significant mood changes, new research suggests that frequent changes in blood-sugar levels (called glycemic variability) also can affect mood and quality of life for those with diabetes.
For example, in a case of an increased risk of depression, diabetes can affect mood even from minute to minute. For example, someone who experiences low blood sugar may suddenly become irritable, even combative, and may act as if they are drunk, slurring their words. Although diabetes and blood-sugar levels can affect emotions, emotions also can affect patients' blood-sugar levels and diabetes control.
Will type 1 diabetes cause a danger to our civilization?
It will not bring a danger to the entire population. However, there might be other autoimmune diseases seen with increased frequency in Type 1 diabetes as the most common form of autoimmune disease in families with Type 1 diabetes will be the thyroid disease.
4. Cure
Cure; can anything be done against the disease or against the symptoms; medicines; including TCM (Traditional Chinese Medicine ).
Treatment for Type 1 diabetes
Type 1 diabetes is incurable but is controllable. It can be treated by administering insulin, either using injection or pump. Not only that, a healthy balanced diet and regular physical exercising can also help.
Against the disease (the purpose of doing all these is to keep your blood sugar as close to normal as possible to delay or prevent more complications.)
Medication
Medication includes injection in which using a needle and syringe to inject insulin under your skin, insulin pumps in which is a device which has a tube that connects a reservoir of insulin to a catheter that's inserted under the skin of your abdomen.
There are other medications such as:
Traditional Chinese Medicine(TCM)
5. Origin of disease
Origin of disease; if genetic, is it dominant, recessive, autosomal, etc; viral; bacterial; etc.
Genetic- More than 50 well validated genes are associated with type 1 diabetes, which can be dominant, recessive or somewhere in between. The risk of a child developing type 1 diabetes is about 10% if the father has it, about 10% if a sibling has it, about 4% if the mother has type 1 diabetes and was aged 25 or younger when the child was born, and about 1% if the mother was over 25 years old when the child was born.
Environmental- For identical twins, when one has a type 1 diabetes, the other twin would have it about 30-50% of the time. Thus, for 50-70 % of the identical twins, one would have it and the other would not. Other indications of environmental influence include the presence of a 10-fold difference in occurrence among Caucasians living in different areas of Europe, and that people tend to acquire the rate of disease of their particular destination country.
Viral- As type 1 diabetes being a virus-triggered autoimmune response in which the immune system would attack the virus infected cells along with the beta cells in the pancreas.
Chemical and drugs- Pyrinuron (Vacor), a rodenticide introduced in the United States in 1976, selectively destroys pancreatic beta cells, resulting in type 1 diabetes after ingestion. Pyrinuron was withdrawn from the U.S. market in 1979 but is still used in some countries. .Streptozotocin (Zanosar), an antibiotic and antineoplastic agent used in chemotherapy for pancreatic cancer which kills beta cells, resulting in loss of insulin production.
Other pancreatic problems, including trauma, pancreatitis, or tumors (either malignant or benign) can also lead to loss of insulin production.
References
Links
Topic 1
What is bioinformatics?
Genome Projects
Prokaryotic cells
Eukaryotic cells
Cell Differentiation
Central Dogma
Translation
Transcription
Gene Finding
Evolutionary biology
are from the same protein family.
Protein Modeling
Databases and Search Tools
Blast
Restriction Enzymes
Cloning
Joining DNA
DNA Denaturation & Hybridization
Hyperchromic shift
DNA Hybridization
Southern Blot
Northern Blot
Western Blot
Gel Electrophoresis
Molecular biology
TOPIC 2
Bio-Database and Computational Biology
Genetic and Physical Mapping
Protein structure Modeling
Single Nucleotide Polymorphism
Expressed Sequence Tags
Microarrays
Topic 3
Human Genome Project
DNA Sequencing by Sanger method
Automated sequencing Method
Manual sequencing Vs Automated sequencing
Shotgun Sequencing method
What is pairwise sequence alignment?
Importance of pairwise sequence alignment
How to determine which is the best alignment?
Biological Motivation Sequence Alignment
Homology
What are the issues in sequence Alignment?
What are Gaps?
Global Alignment (Needleman-Wunsch algorithm)
Local Alignment (Smith-Waterman algorithm)
Semi-global Alignment
Pseudocode
Traceback
Scoring an alignment
What is the use of a scoring matrix in sequence alignment?
Substitution Matrices - PAM Matrices
- It is also known as Point/Percent Accepted Mutation (PAM) Matrices.
Substitution Matrices - BLOSUM Matrices
Dot Plot
Database Searching Tools - BLAST, FASTA
Topic 4
Multiple Sequence Alignment (MSA)
- It produces pairwise sequence alignment which has more than two sequences.
- The input has more than 2 sequences in a set and is a method for scoring an alignment.
- The output determines the connection between the sequences such that it maximises similarity or minimises divergence distance.
Motivation
- It is a set of sequences in characters.
- It characterized a protein family into two groups:
- What is conserved
- It reveals the precise conserved family characteristics, evolution relations
- What varies
- Evolution and development biology, mutation’s effects
- Substitution rates and tendencies
- Profiles and patterns for searching
- Protein modelling
- Construction of phylogenies
MSA scoring
- The problem: It is assumed that the sum of column scores is the alignment score.
- To get an accurate MSA, the alignment score should be the sum of column scores with a score assigned to each column.
- To score a column, there should be a function with k arguments where k is the number of sequences.
- Hence, we can use the Sum-of-Pairs (SP) function to solve this problem.
- SP scoring is the adding of scores of pairwise alignments in each column.
- SP scoring is widely used due to its simplicity and effectiveness.
Methods for MSA
- Multidimensional Dynamic Programming
- Star alignment
- ClustalW
- Profile Hidden Markov Models (HMMs) with Baum-Welch and Viterbi Algorithms
- Expectation Maximization (EM) Algorithm
Dynamic Programming (DP) Approach
- It is used with 2 Sequences.
-Relatively easy in coding
-100% chance in obtaining optimal alignment
- It can be extended to multiple sequences (E.g Amino acid sequences - VSNS, SNA, AS).
-Put one sequence per axis (x,y,z).
- It requires a 3-dimensional array.
Heuristic Alignment Method
- It is used due to complexity of DP approach which is exponential in the number of sequences.
- Progressive alignment: It is the construction of a succession of pairwise alignments. - Star approach
- ClustalW
- Iterative refinement
-Given a multiple alignment, remove the sequence, realign it to a profile of other sequences then repeat until convergence (E.g SAGA, MSASA).
Star Alignment
- Input: k sequences, scoring scheme
- Choose one sequence as the center known as Sc.
- Si is not equal to Sc, determine an optimal pairwise alignment between Si and Sc.
- Compute all the pairwise alignment and select the maximising sequence.
- Sim (Si, Sj) denotes the score of optimal global alignment score of sequence Si, Sj.
- Aggregate pairwise alignment
- It uses “once a gap, always a gap” technique.
- It shifts the entire column when incorporating gaps
- Output: MSA result from aggregate
Progressive Alignment Method
- Multiple alignments are made using progressive alignment methods.
- The alignments are constructed by adding one sequence at a time to a growing alignment.
- Basic progressive alignment steps:
- 1) It determines the distance between the sequences.
- 2) It uses the distance based method to construct a phylogenetic tree for the sequence.
- 3) It adds sequences to the growing alignment using the order given by the tree.
- Progressive alignments are fast to allow hundreds and thousands of sequences to be aligned ( E.g: ClustalW).
ClustalW
- Pairwise alignment: Calculate distance matrix
- Creation of unrooted Neighbor-Joining (NJ) Tree
- Rooted NJ tree and calculate sequence weights
- Progressive alignment following the guide tree (NJ tree)
Problems with Progressive Alignment
- Not 100% guarantee that a global optimal solution will be found.
- It uses “once a gap, always a gap” technique.
- Any mistakes made in any alignment cannot be changed as new information from other sequences is added.
- When all sequences are highly divergent ( E.g less than 25-30% identity between any pair), the progressive alignment becomes less reliable.
- Once a group of sequences have been aligned, their alignments cannot be changed at later stages.
Integrated Approach
- It aligns similar sequences easily.
- It generates an alignment and a phylogenetic tree at same time.
- It requires many rounds of phylogenetic analysis and sequence alignment.
Integrated Approach - Strategies
3) Realign the sequences progressively in order of the relatedness.
4) Construct a new tree from pairwise distances obtained in new multiple alignment.
5) Repeat the process if the new tree is different from the previous one.
Phylogenetic Tree
- It is a diagram of evolutionary lineage of species or genes.
- It is constructed to understand lineage of various species and how the various functions are evolved.
- It informs multiple alignments.
- Examples of Phylogenetic Tree include Tree of life, Kinesin KHC subfamily sequences and Classification of Languages.
- Tree of life is a phylogenetic study of how the evolution of species occurred.
- Kinesin is a mechanochemical protein capable of utilizing chemical energy from ATP hydrolysis to generate mechanical force.
Basics of Phylogenetic Tree
- They are made by arranging nodes and branches.
- Each node represents a distinct taxonomic unit.
- Terminal nodes or leaves correspond to a gene or organism which data have been collected for analysis.
- Internal nodes representing an inferred common ancestor giving rise to two independent lineage in the past are also known as hypothetical ancestral units.
- Leaves represent things such as genes, species being compared.
- Rooted tree with a path from root to a node represents an evolutionary path.
- Unrooted tree specifies relationships among things, but not evolutionary paths.
Data for Building Trees
- Distance-based data measures the distance between species, genes or languages.
- Character-based data consists of morphological features, DNA or protein sequences.
- Gene-order data is the linear order of orthologous genes in given genomes.
Background on Trees
- All trees are binary with edges that branches split into two daughter edges.
- Types of trees :
- Rooted or Unrooted,
- Scaled or Unscaled
- Computer programs conveying basic information about a structure of a phylogenetic tree in a series of nested parentheses are also known as Newick format.
Phylogenetic Tree Approach
- Distance : Find the tree involved in estimated evolutionary distances.
- Parsimony : Find the tree that explains the data with a minimal number of changes.
- Maximum likelihood : Find the tree maximising the likelihood of the data.
UPGMA Method
- It is also known as the Unweighted Pair Group Method using Arithmetic Averages/Means (UPGMA) Method.
- It produces rooted trees.
- The basic Idea includes picking two taxa or clusters and merging them together to create a new node in the tree for the merged cluster.
- It starts with clustering two species with the smallest distance separating them into a single composite group.
- After that, a new distance matrix is computed with the distance between the new composite group and the remaining species calculated.
- Species that are separated by the smallest distance are clustered together to make a new composite species.
- The process is repeated until all the species are grouped.
- Scaled branch lengths are used on the tree to show the evolutionary distance between species.
- Branch points are at halfway distance between each of the species being grouped.
UPGMA
- It assumes a constant mutation rate for all branches.
- Hence, this satisfies a molecular clock with constant rate.
- The correct tree is constructed if the tree does not satisfy a molecule clock and the distance data is ultrametric.
- Ultrametric test condition: It is tested when any triplet I,j,k are either all equal or both are equal and the remaining is smaller.
- The fit of the realized tree is assessed to the data by adding squares of differences between the measured distances and those from the tree.
Fitch Margoliash Method
- It constructs a tree by iteratively joining subtrees.
- It does not make molecular clock assumptions.
- It produces unrooted trees.
- It has higher accuracy calculation of branch lengths.
Parsimony
- Find the tree that explains the data with a minimal number of changes.
- The tree requiring the least inferred mutations is the correct tree.
- Input: Character-based data
- It does not provide a method in constructing the tree topology, but a principle for deciding the best topology.
MSA and Phylogenetic Trees
- It is an integrated or unified approach to generate an alignment and a phylogeny.
- It has difficulty in aligning multiple sequences that is computational.
- The order in which the sequences are added to a multiple alignment can significantly affect the end result.
- The branching order of the sequences being studied should be taken into consideration for the alignment of multiple sequences due to higher accuracy and easier alignment of similar sequences.
- When the phylogeny of sequences being aligned is known before the alignment is made, sequences will be added one at a time to the growing multiple alignment with the most related sequence added first and the least related sequence added last.
- Phylogenetic relationships are determined by analysing the sequences.
MSA and Phylogenetic Trees - Strategies
1) Generate a pairwise distance matrix using possible pairwise alignment.
2) Use UPGMA or Fitch-Margoliash to construct the initial tree.
3) Realign the sequences progressively in order of the relatedness.
4) Construct a new tree from pairwise distances obtained in new multiple alignment.
5) Repeat the process if the new tree is different from the previous one. This requires many rounds of phylogenetic analysis and sequence alignment.
Additional information :
Part 1 of 3: What is type 2 diabetes?
Diabetes mellitus type 2 (formerly non insulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes) is a metabolic disorder that is characterized by hyperglycemia (high blood sugar) in the context of insulin resistance and relative lack of insulin.
Type 2 diabetes is a chronic disease that can cause blood sugar (glucose) to be higher than normal. In addition, many people do not feel symptoms with type 2 diabetes. However, there are some common symptoms that it is important to be aware of. These are examples of symptoms for type 2 diabetes when blood sugar levels are abnormally high.
The most common symptoms of type 2 diabetes include:
Part 2 of 3: Common Symptoms
If you have diabetes, it can help to understand how your blood sugar levels affect the way you feel. Most common symptoms of diabetes are caused by elevated glucose levels.
Elevated glucose levels force fluids from your cells. This increases the amount of fluid delivered to the kidneys. This results in urinating frequently which eventually causes one to become dehydrated.
As your tissues become dehydrated, you will become thirsty. Increased thirst is another common diabetes symptom. As, the more you urinate, the more you need to drink, and vice versa.
Feeling worn down is another common symptom of diabetes. Glucose is normally one of the body’s main sources of energy. When cells cannot absorb sugar, you can become fatigued or feel exhausted.
Due to high glucose levels can cause a swelling of the lens in the eye. This leads to blurry vision. Getting your blood sugar under control can help correct vision problems. If blood sugar levels remain high for a long time, other eye problems can occur.
Elevated glucose levels may make it harder for your body to heal. Therefore, injuries like cuts and sores stay open longer. Which results in making them more susceptible to infection.
Others:
Very often, people don’t notice that they have high blood sugar levels because they don’t feel any symptoms. High blood sugars can lead to long term problems, such as a higher risk for heart disease, foot problems, nerve damage, eye diseases, and kidney disease. People with diabetes are also at risk for serious bladder infections. In people without diabetes, bladder infections are usually painful. However, diabetics may not have that sensation of pain with urination. The infection may not be detected until it has spread to the kidneys.
Part 3 of 3: Emergency Symptoms
As stated, high blood sugar causes long-term damage to the body. However, low blood sugar, called hypoglycemia, can be a medical emergency. Hypoglycemia occurs when there are dangerously low levels of blood sugar. For people with type 2 diabetes, only those people who are on medications that increase the body’s insulin levels are at risk for low blood sugar.
Symptoms of hypoglycemia include:
If you are on medicines that increase the amount of insulin in your body, be sure you know how to treat low blood sugar.
Type 2 diabetes occurs when the pancreas doesn't produce enough insulin to maintain a normal blood glucose level, or the body is unable to use the insulin that is produced – known as insulin resistance.
The pancreas (a large gland behind the stomach) produces the hormone insulin, which moves glucose from your blood into your cells, where it's converted into energy.
In type 2 diabetes, there are several reasons why the pancreas doesn't produce enough insulin.
Four of the main risk factors for developing type 2 diabetes are:
Age
Your risk of developing type 2 diabetes increases with age. Especially being over the age above 40. This may be because people tend to gain weight and exercise less as they get older.
Maintaining a healthy weight by eating a healthy, balanced diet and exercising regularly are ways of preventing and managing diabetes.
White people over the age of 40 have an increased risk of developing type 2 diabetes. People of south Asian, Chinese, African-Caribbean and black African descent have an increased risk of developing type 2 diabetes at a much earlier age.
However, despite increasing age being a risk factor for type 2 diabetes, over recent years younger people from all ethnic groups have been developing the condition.
It's also becoming more common for children, in some cases as young as seven, to develop type 2 diabetes.
Genetics is one of the main risk factors for type 2 diabetes.
Your risk of developing the condition is increased if you have a close relative – such as a parent, brother or sister – who has the condition. The closer the relative, the greater the risk.
A child who has a parent with type 2 diabetes has about a one in three chance of also developing it (see below).
You're more likely to develop type 2 diabetes if you're overweight or obese (with a body mass index (BMI) of 30 or more).
In particular, fat around your tummy (abdomen) increases your risk. This is because it releases chemicals that can upset the body's cardiovascular and metabolic systems.
This increases your risk of developing a number of serious conditions, including coronary heart disease, stroke and some types of cancer.
Measuring your waist is a quick way of assessing your diabetes risk. This is a measure of abdominal obesity, which is a particularly high-risk form of obesity.
Women have a higher risk of developing type 2 diabetes if their waist measures 80cm (31.5 inches) or more. Asian men with a waist size of 89cm (35 inches) or over have a higher risk, as do white or black men with a waist size of 94cm (37 inches) or over.
Use the BMI calculator to find out if you're a healthy weight for your height.
Exercising regularly and reducing your body weight by about 5% could reduce your risk of getting diabetes by more than 50%.
Read more about losing weight.
People of south Asian, Chinese, African-Caribbean and black African are more likely to develop type 2 diabetes.
Type 2 diabetes is up to six times more common in south Asian communities than in the general UK population, and it's three times more common among people of African and African-Caribbean origin.
People of south Asian and African-Caribbean origin also have an increased risk of developing complications of diabetes, such as heart disease, at a younger age than the rest of the population.
Your risk of developing type 2 diabetes is also increased if your blood glucose level is higher than normal, but not yet high enough to be diagnosed with diabetes.
This is sometimes called "pre-diabetes" – doctors sometimes call it impaired fasting glycaemia (IFG) or impaired glucose tolerance (IGT).
Pre-diabetes can progress to type 2 diabetes if you don't take preventative steps, such as making lifestyle changes. These include eating healthily, losing weight (if you're overweight) and taking plenty of regular exercise.
Women who have had gestational diabetes during pregnancy also have a greater risk of developing diabetes in later life.
The three main types of diabetes are type 1, type 2, and gestational diabetes. People can develop diabetes at any age. Both women and men can develop diabetes.
Type 1 diabetes, which used to be called juvenile diabetes, develops most often in young people; however, type 1 diabetes can also develop in adults. In type 1 diabetes, your body no longer makes insulin or enough insulin because the body's immune system, which normally protects you from infection by getting rid of bacteria, viruses, and other harmful substances, has attacked and destroyed the cells that make insulin.
Type 2 diabetes, which used to be called adult-onset diabetes, can affect people at any age, even children. However, type 2 diabetes develops most often in middle-aged and older people. People who are overweight and inactive are also more likely to develop type 2 diabetes.
Type 2 diabetes usually begins with insulin resistance—a condition that occurs when fat, muscle, and liver cells do not use insulin to carry glucose into the body’s cells to use for energy. As a result, the body needs more insulin to help glucose enter cells. At first, the pancreas keeps up with the added demand by making more insulin. Over time, the pancreas doesn’t make enough insulin when blood sugar levels increase, such as after meals. If your pancreas can no longer make enough insulin, you will need to treat your type 2 diabetes.
Treatment for type 2 diabetes includes
Gestational diabetes can develop when a woman is pregnant. Pregnant women make hormones that can lead to insulin resistance. All women have insulin resistance late in their pregnancy. If the pancreas doesn’t make enough insulin during pregnancy, a woman develops gestational diabetes.
Overweight or obese women have a higher chance of gestational diabetes. Also, gaining too much weight during pregnancy may increase your likelihood of developing gestational diabetes.
Gestational diabetes most often goes away after the baby is born. However, a woman who has had gestational diabetes is more likely to develop type 2 diabetes later in life. Babies born to mothers who had gestational diabetes are also more likely to develop obesity and type 2 diabetes.
Genes that have been associated with type 2 diabetes risk include:
TCF7L2 :
TCF7L2 (Transcription Factor 7-Like 2 (T-Cell Specific, HMG-Box)) is a Protein Coding gene. Diseases associated with TCF7L2 include pitt-hopkins syndrome and tropical calcific pancreatitis. Among its related pathways are Signaling by GPCR and Pathways in cancer.
CF7L2 was discovered as a type 2 diabetes susceptibility gene after a strong linkage signal was mapped to chromosome 10q in a Mexican-American population. This region was later fine-mapped in the Icelandic population and confirmed in United States and Danish cohorts, where the risk locus was found to be located in intron 3 of the TCF7L2 gene. There are indications that this gene may play a role in cancer as well as in diabetes.[9]
TCF7L2 is a transcription factor and key component of the Wnt signaling pathway, and it is involved in the development of a wide variety of cell lineages and organs.[10] Potential mechanisms through which TCF7L2 variants influence type 2 diabetes include its role in adipogenesis, myogenesis, and pancreatic islet development, as well as in beta-cell survival and insulin secretory granule function.[11, 12] It is also involved in the transcriptional regulation of the genes for proglucagon and the glucagon-like peptides GLP-1 and GLP-2; these peptides play a role in postprandial insulin secretion.[13]
Finally, TCF7L2 polymorphisms have been associated with impaired insulin secretion, glucose production, and glucose tolerance via direct effects on pancreatic islet beta cells.[14, 15] Indeed, dysregulation of glucose metabolism, decreased processing of proinsulin, and elevated levels of gastric inhibitory peptide and glycated hemoglobin (HbA1c) can be observed in normoglycemic individuals with TCF7L2 polymorphisms before the onset of type 2 diabetes.[16, 17]
Relevant genes towards TCF7L2 :
Acts as repressor in the absence of CTNNB1, and as an activator in its presence. Activates transcription from promoters with several copies of the Tcf motif 5'-CCTTTGATC-3' in the presence of CTNNB1. TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by TCF7L2/TCF4 and CTNNB1. Expression of dominant-negative mutants results in cell-cycle arrest in G1. Necessary for the maintenance of the epithelial stem-cell compartment of the small intestine.
What is ABCC8?
The gene is known as “ATP binding cassette subfamily C member 8.”
Pancreatic β-cell ATP-sensitive K(+) (K(ATP)) channels are composed of Kir6.2 and SUR1 subunits encoded by the KCNJ11 and ABCC8 genes, respectively. Although rare monogenic activating mutations in these genes cause overt neonatal diabetes, the common variants E23K (KCNJ11) and S1369A (ABCC8) form a tightly heritable haplotype that is associated with an increased susceptibility to type 2 diabetes (T2D) risk.
Furthermore, Sulfonylureas are a class of drugs used to lower blood glucose in the treatment of type 2 diabetes. These drugs interact with the sulfonylurea receptor of pancreatic beta cells and stimulate insulin release. The sulfonylurea receptor is encoded by the ABCC8 gene, and genetic variation of ABCC8 may impair the release of insulin.
What is GLUT2?
Glucose transporter 2 (GLUT2) also known as solute carrier family 2 (facilitated glucose transporter), member 2 (SLC2A2) is a transmembrane carrier protein that enables protein facilitated glucose movement across cell membranes.
What is GCGR?
GCGR (Glucagon Receptor) is a Protein Coding gene. Diseases associated with GCGR include diabetes mellitus, non insulin-dependent and hyperglycemia. Among its related pathways are Signaling by GPCR and Activation of cAMP-Dependent PKA.
Glucagon is the main secretory product of the pancreatic alpha-cells. The main function of this peptide hormone is to provide sustained glucose supply to the brain and other vital organs during fasting conditions. This is exerted by stimulation of hepatic glucose production via specific G protein-coupled receptors in the hepatocytes. Type 2 diabetic patients are characterized by elevated glucagon levels contributing decisively to hyperglycemia in these patients. Accumulating evidence demonstrates that targeting the pancreatic alpha-cell and its main secretory product glucagon is a possible treatment for type 2 diabetes. Several lines of preclinical evidence have paved the way for the development of drugs, which suppress glucagon secretion or antagonize the glucagon receptor.
References: